✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
PBT-1033 is an investigational drug.
There have been 7 clinical trials for PBT-1033. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2008.
The most common disease conditions in clinical trials are Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, and Endometrial Neoplasms. The leading clinical trial sponsors are GlaxoSmithKline, M.D. Anderson Cancer Center, and Mayo Clinic.
Recent Clinical Trials for PBT-1033
|Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT||Jarrow Formulas Inc||Phase 1/Phase 2|
|Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT||University of California, Irvine||Phase 1/Phase 2|
|The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach||University of Maryland, Baltimore||Phase 2|